BeStock  
Stocks › Biotechnology › ABVX

Abivax S.A. ABVX

US equityMarket cap rank #1799Biotechnology
$73.20 −$7.45 (-9.24%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $74.95 +2.39%
Open$79.01
Prev close$80.65
Day range$62.70 – $79.74
Volume14.85M
Market cap$6.41B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts9
Average target$160.56+119.3% vs. price
  • Buy 89%
  • Hold 11%
Low $118.00Now $73.20Avg $160.56High $180.00

Recent rating changes

The last 20 actions on file set price targets from $118.00 to $180.00, averaging $165.32.

DateFirmRatingTarget
21 Oct 2026 Piper Sandler BUY $175.00
20 Oct 2026 Guggenheim BUY $175.00
20 Oct 2026 Barclays BUY $148.00
1 Oct 2026 BTIG BUY $175.00
28 Sep 2026 BTIG BUY $175.00
28 Sep 2026 Morgan Stanley BUY $180.00
22 Sep 2026 LifeSci Capital BUY $168.00
22 Sep 2026 BTIG BUY $175.00
22 Sep 2026 Truist Financial BUY $151.00
22 Sep 2026 Wedbush HOLD $118.00
22 Sep 2026 Morgan Stanley BUY $180.00
22 Sep 2026 Barclays BUY $148.00
9 Sep 2026 Goldman Sachs BUY $155.00
24 Jul 2026 Morgan Stanley BUY $180.00
9 Jul 2026 Piper Sandler BUY $175.00
2 Jul 2026 Truist Financial BUY $155.00
1 Jul 2026 Jefferies BUY $158.00
1 Jul 2026 Guggenheim BUY $175.00
30 Jun 2026 BTIG BUY $175.00
30 Jun 2026 Truist Financial BUY –

Discussion

No comments yet — be the first to weigh in on ABVX.

Sign in to join the discussion.

Scroll to Top